INNOVA CAPTAB
Back to Cashflow Statement
|
INNOVA CAPTAB Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹27 Cr | ₹125 Cr | ₹-19 Cr | ₹-23 Cr | ₹-9.20 Cr |
What is the latest Cash Flow from Financing Activities ratio of INNOVA CAPTAB ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹27 Cr |
Mar2022 | ₹125 Cr |
Mar2021 | ₹-19 Cr |
Mar2020 | ₹-23 Cr |
Mar2019 | ₹-9.20 Cr |
How is Cash Flow from Financing Activities of INNOVA CAPTAB Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹27 Cr | -78.25 | |
Mar2022 | ₹125 Cr | Positive | |
Mar2021 | ₹-19 Cr | Negative | |
Mar2020 | ₹-23 Cr | Negative | |
Mar2019 | ₹-9.20 Cr | - |
Compare Cash Flow from Financing Activities of peers of INNOVA CAPTAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INNOVA CAPTAB | ₹2,688.1 Cr | 2% | 0.1% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹370,757.0 Cr | 1.6% | -3.7% | 60% | Stock Analytics | |
CIPLA | ₹109,559.0 Cr | -2% | -4.6% | 49.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,416.0 Cr | -0.9% | 4.2% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,088.9 Cr | -2.1% | -0.9% | 89.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,939.0 Cr | -3.1% | -4.7% | 21.6% | Stock Analytics |
INNOVA CAPTAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INNOVA CAPTAB | 2% |
0.1% |
|
SENSEX | -0.6% |
-2.1% |
18.4% |
You may also like the below Video Courses